Christopher Ray Aker

Companies

• Regulus Therapeutics Inc.General counsel Jan 2, 2019 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RTRegulus Therapeutics Inc.0 shares²Jun 25, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 25, 2025Returned to company 83,125 shares of Regulus Therapeutics Inc.²
• Jun 25, 2025U 60,796 shares of Regulus Therapeutics Inc.²
• Jan 14, 2025Sold 5,088 shares at $1.26 of Regulus Therapeutics Inc.³
• Jan 13, 2025Sold 38,547 shares at $1.26 of Regulus Therapeutics Inc.³
• Jan 9, 2025Granted 17,500 shares at $1.30 of Regulus Therapeutics Inc.⁴
• Jan 9, 2025Granted 66,625 shares at $1.36 of Regulus Therapeutics Inc.⁴
• Jan 18, 2024Sold 5,468 shares at $1.19 of Regulus Therapeutics Inc.⁵
• Jan 12, 2024Granted 11,250 shares of Regulus Therapeutics Inc.⁶